Condition
Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma
Estimated Enrollment: 54
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: NCI-2012-02902|S0509|U10CA032102|CDR0000446178
Study First Received: October 20, 2005
Last Updated: September 21, 2015
Estimated Primary Completion Date: April 2010
Primary Outcome Measures:
Overall Response Rate|Overall Survival|Progression-free Survival|Disease Control Rate|Objective Response Rate Per Modified RECIST for Pleural Tumors|Adverse Event Rates|Adverse Events
Sponsors and Collaborators:
National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00243074
